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Abstract
Objective: Nitric oxide exerts its cardiovascular actions at least in part by modulation of the sympathetic vasoconstrictor tone. There is
increasing evidence that nitric oxide inhibits central neural sympathetic outflow, and preliminary evidence suggests that it may also
modulate peripheral sympathetic vasoconstrictor tone. Methods: To test this latter concept, in six subjects having undergone thoracic
sympathectomy for hyperhydrosis, we compared the vascular responses to systemic L-NMMA infusion (1mg/kg/min over 10 min) in the
innervated and the denervated limb. We also studied vascular responses to the infusion of the non-nitric-oxide-dependent vasoconstrictor
phenylephrine. Results: L-NMMA infusion evoked a roughly 3-fold larger increase in vascular resistance in the denervated forearm than
in the innervated calf. In the denervated forearm, vascular resistance increased by 58610 percent (X6SE), whereas in the innervated calf
it increased only by 2166 percent (P,0.01, forearm vs. calf). This augmented vasoconstrictor response was specific for L-NMMA, and
not related to augmented non-specific vasoconstrictor responsiveness secondary to sympathectomy, because phenylephrine infusion
increased vascular resistance similarly in the denervated forearm and the innervated calf (by 2467, and 2968 percent, respectively). The
augmented vasoconstrictor response was related specifically to denervation, because in control subjects, the vasoconstrictor responses to
L-NMMA were comparable in the forearm and the calf. Conclusions: These findings indicate that in the absence of sympathetic
innervation, the vasoconstrictor responses to nitric oxide synthase inhibition are augmented. Ó 1999 Elsevier Science B.V. All rights
reserved.
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1. Introduction its cardiovascular actions at least in part by modulating the
sympathetic vasoconstrictor tone [6–8]. Regarding the
Nitric oxide which is synthesized by the endothelium latter, two concepts have been proposed. First, in both
from the amino acid L-arginine by the ubiquitous enzyme animals [6–8], and humans [9], nitric oxide inhibits central
nitric oxide-synthase [1], has emerged as a key regulatory neural vasoconstrictor outflow. More recently, it has been
mechanism of blood pressure and vasomotor tone in both suggested that nitric oxide also may modulate sympathetic
animals and humans [2,3]. While there is abundant evi- tone peripherally [10], as evidenced by the suppression of
dence that nitric oxide exerts its vasodilator action at least the L-NMMA induced pressor effect by sympathectomy in
in part by a direct effect at the vascular smooth muscle cell anesthetized, paralyzed, baroreflex-denervated cats [11].
[4], more recent evidence suggests that nitric oxide which To test this latter concept, we examined vasoconstrictor
is also synthesized in the central nervous system [5], exerts responses to systemic L-NMMA infusion in the innervated
calf and the denervated forearm in subjects having under-
gone thoracic sympathectomy for hyperhydrosis. We com-
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2. Methods arginine (100 mg/kg over 10 min). Hemodynamic mea-
surements were recorded during two 5 min periods of the
2.1. Subjects saline infusion, and 5 min after the end of each of the drug
infusions. The present dose of L-NMMA was chosen,
We studied six healthy subjects (2 men and 4 women, because it has been shown to consistently increase calf
mean [6SD] weight 6463 kg, height 16764 cm, body vascular resistance. [13]
2
mass index 22.861.1 kg/m , age 3466 years) having To demonstrate the efficacy of thoracic sympathectomy,
undergone thoracic sympathectomy for hyperhydrosis we measured blood pressure and limb blood flow re-
(mean [6SD] time from surgery at the time of the study sponses to 2 min immersion of the hand in ice water [14],
was 4067 months), and five age- and sex-matched control and compared vasoconstrictor responses in the denervated
subjects (weight 7063 kg, height 17664 cm, body mass and innervated limbs during the second minute of this test.
2index 22.461.1 kg/m , age 3065 years). Vasoconstrictor responses to immersion of the hand in ice
All subjects were normotensive, were taking no medica- water in the sympathetically denervated forearm were
tions, and had no evidence of metabolic or cardiovascular abolished; during the second minute of the cold pressor
disease. The studies were performed in the morning after test, vascular resistance had increased by 48620 percent in
an overnight fast. The subjects were asked to abstain from the innervated limb, whereas it had decreased by 1765
alcohol, caffeine and tobacco for at least 24 h before each percent in the denervated limb (P,0.02 innervated vs.
study. The investigation conforms with the principles denervated limbs).
outlined in the Declaration of Helsinki. The experimental Protocol 2: Cardiovascular effects of equipressive dose
protocol was approved by the Institutional Review Board of phenylephrine infusion. Four of the subjects having
on Human Investigation, and all subjects provided written undergone thoracic sympathectomy returned for this study
informed consent. during which, after 30 min of normal saline infusion (1
ml /min), they received a phenylephrine infusion titrated at
2.2. General procedures a dose to match the increase in arterial pressure observed
during the L-NMMA infusion. Hemodynamic measure-
The subjects were studied in the supine position. Heart ments were recorded during two 5 min periods of the
rate (electrocardiogram) and blood pressure (Finapres) saline and the phenylephrine infusion.
were measured continuously. For drug infusion, an in-
travenous catheter was inserted in an antecubital vein.
3. Data analysis
2.3. Measurement of muscle blood flow
Mean arterial pressure was calculated as diastolic pres-
Limb blood flow was measured by venous occlusion sure plus 1 /3 pulse pressure. Vascular resistance was
plethysmography, using mercury-in-Silastic strain gauges. determined as mean arterial pressure in mmHg divided by
The limbs were elevated 10 to 15 cm above the level of the blood flow in ml /min per 100 ml of tissue. The measure-
right atrium to collapse the veins. The circulation to the ments of limb blood flow, arterial pressure, and heart rate
hand and the foot was arrested by inflating a cuff around that were collected over 5 min periods were averaged to a
the wrist and the ankle during blood flow determinations, single value.
which were performed at 15-second intervals over a 5-min Statistical analysis was performed using paired and
period. [12] unpaired two-tailed t-tests, as appropriate. A P value
,0.05 was considered to indicate significance. Unless
2.4. Drugs stated otherwise, data are expressed as means6SE.
Drugs were dissolved in physiological saline immedi-
ately before use. L-NMMA, L-arginine, and D-arginine 4. Results
¨were obtained from Clinalfa (Laufelfingen, Switzerland),
and phenylephrine from Winthrop Pharmaceuticals In the subjects having undergone thoracic sympathec-
(Zurich, Switzerland). tomy, the base-line vascular resistance (Table 1) in the
denervated forearm and the innervated calf was compar-
2.5. Experimental protocols able (P50.9). The base-line vascular resistance in the
denervated forearm was also not different (P50.3) from
Protocol 1: Cardiovascular effects of L-NMMA infusion. the baseline vascular resistance in the control subjects.
After instrumentation the subjects rested quietly for 30 Figs. 1 and 2 show that L-NMMA infusion evoked a
min. They then received sequential infusions of normal roughly 3-fold larger increase in vascular resistance in the
saline (1 ml /min for 20 min), L-NMMA (1mg/kg/min for denervated forearm than in the innervated calf. In the
10 min), D-arginine (100 mg/kg over 10 min), and L- forearm, vascular resistance increased by 58610 percent
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Table 1
aHemodynamic responses to L-NMMA and phenylephrine infusion
Subjects with sympathectomy Control subjects
Basal L-NMMA D-arginine L-arginine Basal Phenylephrine Basal L-NMMA
infusion infusion infusion infusion infusion
Mean arterial pressure
b b b c(mm/Hg) 7965 9464 8964 8065 7864 9462 7864 9462
Heart rate
c
b c b(beats /min) 6262 5262 5163 6162 6362 5363 5762 4862
Forearm blood flow
c b(ml /min /100 ml) 1.960.1 1.460.1 1.460.2 1.860.2 1.760.2 1.660.2 1.660.2 1.660.1
Calf blood flow
(ml /min /100 ml) 1.960.3 1.960.3 1.860.4 2.060.1 1.760.3 1.660.3 1.760.2 1.660.1
Forearm vascular resistance
c b b b(Units) 4365 6866 6464 4462 4766 5965 5064 5963
Calf vascular resistance
b b b b(Units) 4269 51612 4964 4167 4867 6065 4765 6064
a Values are means6SE for six subjects with sympathectomy (except for phenylephrine and D-arginine infusion; n54), and five control subjects.
b P,0.05 vs. corresponding base-line.
c P,0.01 vs. corresponding base-line.
during L-NMMA infusion whereas in the calf, it increased studies suggest that it does so, at least in part, by
only by 2166 percent (P,0.001, forearm vs. calf). The modulating sympathetic vasoconstrictor outflow [15]. Here
L-NMMA induced vasoconstriction was reversed by L- we used subjects having undergone thoracic sympathec-
arginine, but not by D-arginine, infusion (Table 1). In tomy for hyperhydrosis, to probe the role of the peripheral
contrast to L-NMMA, infusion of an equipressive dose of sympathetic nervous system in the modulation of the
phenylephrine increased the vascular resistance comparab- vascular responsiveness to nitric oxide synthase inhibition.
ly in the denervated and the innervated limb (by 2463 and We found that sympathectomy markedly potentiated the
2667 percent, respectively; P.0.5, forearm vs. calf). vasoconstrictor effect of L-NMMA infusion. The L-NMMA
In the control subjects, the vascular responses to L- induced vasoconstrictor effect was almost three times
NMMA infusion in the forearm and the calf were compar- larger in the denervated than in the innervated limb. These
able (Table 1). findings provide the first evidence for an important inter-
play between the peripheral sympathetic nervous system
and the L-arginine–nitric-oxide system in the regulation of
5. Discussion the vascular tone in humans, and indicate that sympathetic
innervation attenuates the vasoconstrictor effect of nitric
Nitric oxide has emerged as a key regulatory mechanism oxide synthase inhibition.
of vasomotor tone and arterial pressure [2,3]. Recent The augmented L-NMMA-induced vasoconstrictor effect
Fig. 1. Segments of simultaneous recordings of forearm and calf blood flow in a subject with thoracic sympathectomy obtained at base-line, and during
L-NMMA and L-arginine infusion. L-NMMA infusion decreased blood flow in the denervated forarm but not in the innervated calf. This effect was reversed
by L-arginine infusion.
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sympathetic denervation potentiates the vasoconstrictor
effects of nitric oxide synthase inhibition. We do not know
yet the underlying mechanism(s) by which sympathetic
innervation attenuates the L-NMMA induced vasoconstric-
tion. It is possible that in denervated limbs, the contribu-
tion of nitric oxide to local vascular resistance regulation
may be augmented, leading to augmented vasoconstrictor
responses during L-NMMA infusion. Alternatively, in
innervated limbs, neuronal, non-nitric-oxide-dependent
vasodilator mechanisms may attenuate the vasoconstrictor
effects of nitric oxide synthase inhibition.
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